Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency (NCT05393882) | Clinical Trial Compass
WithdrawnNot Applicable
Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency
Stopped: Insufficient funding
Hong Kong0Started 2025-09
Plain-language summary
This single-centre cross-sectional study aims to ascertain the impact of dyslipidemia on long-term graft patency after coronary artery bypass grafting (CABG).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- All consecutive patients on record who underwent coronary artery bypass graft surgery in 2007 and 2008
Exclusion Criteria:
* Death
* Single vessel LIMA-LAD anastomosis only
* Concomitant valve and aortic procedures
* Concomitant repair of post-infarct ventricular septal rupture
* Defaulted follow-up
* Informed consent cannot be obtained
* Intermediate to high risk for contrast nephropathy, defined as estimated glomerular filtration rate less than 45 ml/min/1.73m2 or serum creatinine level \<1.5 mg/dL (based on American College of Radiology criteria for diagnostic computed tomography risk)
* Pregnancy